212490-27-2

Upstream product

• 212490-12-5 3-(3,4-Dimethoxy-phenyl)-2-[(3-isopropoxy-4-methoxy-phenyl)-hydrazono]-propionic acid methyl ester 

Downstream Products

• 212489-57-1 2-amino-4-isopropoxy-3',4',5-trimethoxybenzophenone 
• 158147-28-5 4-(3,4-Dimethoxy-phenyl)-7-isopropoxy-6-methoxy-2-[1,2,4]triazol-1-ylmethyl-quinoline-3-carboxylic acid ethyl ester 
• 158147-60-5 2-Chloromethyl-4-(3,4-dimethoxy-phenyl)-7-isopropoxy-6-methoxy-quinoline-3-carboxylic acid ethyl ester 

Relevant academic research and scientific papers

Studies on disease-modifying antirheumatic drugs. II. Synthesis and activity of the metabolites of ethyl 4-(3,4-dimethoxyphenyl)-6,7-dimethoxy- 2-(1,2,4-triazol-1-ylmethyl)quinoline-3-carboxylate (TAK-603)

The metabolites of ethyl 4-(3,4-dimethoxyphenyl)-6,7-dimethoxy-2- (1,2,4-triazol-1-ylmethyl)quinoline-3-carboxylate (1, TAK-603), which is under clinical evaluation as a new type of disease-modifying antirheumatic drug (DMARD), were prepared to confirm th